In a recent study published in the journal Nature Medicine, a group of researchers assessed if a precise blood test matches or surpasses traditional cerebrospinal fluid (CSF) tests in detecting ...

A new blood test that could help doctors identify whether a patient has Alzheimer’s disease was cleared by the FDA last week.

Analysing cancer DNA in spinal fluid could speed up and improve the diagnosis of breast cancer which has spread to the brain and spinal cord, according to a new pilot study. The type of test, known as ...

The FDA recently cleared the Lumipulse blood test for early diagnosis of Alzheimer's disease in people 55 and over with memory loss. The noninvasive Lumipulse blood test measures the levels of two ...

The US Food and Drug Administration has given marketing clearance to a blood test to help diagnose Alzheimer’s disease, making the test the first to get signoff to aid in the early detection of the ...

A simple blood test to diagnose Alzheimer’s disease, which afflicts nearly 7 million Americans, could soon replace more invasive and expensive diagnostic methods such as spinal taps and brain scans.

Subtle changes in the brain, detectable through advanced imaging, blood and spinal fluid analysis, happen approximately 20 ...

The U.S. Food and Drug Administration (FDA) approved the first blood test to detect Alzheimer's disease in what federal officials called an "important step" toward diagnosing and treating the disease ...

Background. Individuals with cryptococcal antigenemia are at high risk of developing cryptococcal meningitis if untreated. The progression and timing from asymptomatic infection to cryptococcal ...

Subtle changes in the brain, detectable through advanced imaging, blood and spinal fluid analysis, happen approximately twenty years before a clinical motor diagnosis in people with Huntington's ...